Apokyn and Memantine
Determining the interaction of Apokyn and Memantine and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.
Professional:Memantine may theoretically enhance the pharmacologic effects of dopaminergic agents. The clinical significance is unknown.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- "Multum Information Services, Inc. Expert Review Panel"
Generic Name: apomorphine
Brand name: Apokyn, APO-Go, APO-Go Pen, Uprima
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Apokyn-Memantine and Donepezil
- Apokyn-Memantine and Donepezil Capsules
- Apokyn-Memantine ER capsules
- Apokyn-Memantine ER Tablets
- Apokyn-Memantine Extended-Release Capsules
- Apokyn-Memantine Hydrochloride
- Memantine-Apomorphine
- Memantine-Apomorphine Ampules
- Memantine-Apomorphine Cartridges and Pens
- Memantine-Apomorphine Hydrochloride
- Memantine-Apomorphine Subcutaneous
- Memantine-Apra